p-p70S6K (Thr 389) expression in nodular sclerosing Hodgkin's disease as evidence for receptor tyrosine kinase signaling

Annals of Clinical and Laboratory Science

Volumn 35, Issue 4, 2005, Pages 413-414

  Brown, Robert E ^a   Kamal, Nazmi R ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

Hodgkin's disease; p70S6K; Receptor tyrosine kinases

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; S6 KINASE; THREONINE;

ARTICLE; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REED STERNBERG CELL;

HODGKIN DISEASE; HUMANS; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SCLEROSIS; SIGNAL TRANSDUCTION;

EID: 27644471917     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Renné C, Willenbrock K, Küppers R, Hansmann, M-L, Bräuninger A. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood 2005;105:4051-4059.
2. Brown, RE, Kamal NR. The Reed-Sternberg cell: molecular characterization by proteomic analysis with therapeutic implications. Ann Clin Lab Sci 2002;32:339-351.
3. Dufner A, Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 1999;253:100-109.
4. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G. Phosphorylation and activation of p70S6K by PDK1. Science 1998;279:707-710.
5. Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 2004;23:5853-5857.
6. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okano S, Kaneko K, Hasegawa M, Hashizume M, Maehara Y, Sueishi K. Essential role of PDGFR-alpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFR alpha during angiogenesis. Circ Res 2004;94:1186-1194.
7. Dutton A, Reynolds GM, Dawson CW, Young LS, Murray PG. Constitutive activation of phosphorylatidylinositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. J Pathol 2005;205:498-506.
8. Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A. MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 2003;102:1019-1027.
9. Brown RE. Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients. Exp Rev Proteomics 2005;2:337-348.